摘要
目的:探讨临床路径在子宫平滑肌瘤切除术患者中的应用价值方法:将60例子宫肌瘤切除术的患者随机均分为2组,路径组30例采用临床路径实施规范化管理,非路径组30例按照常规方法管理比较2组患者的平均住院日、平均住院费用、患者满意度。结果:分析了两组患者的平均住院时间、平均住院费及费用构成,平均住院时间、平均住院费的对应t值分别为(4.42)、(3.52)、差异有统计学意义(P<0.05);实验组患者满意度与对照组满意度比较,t值为(3.05),差异有统计学意义(P<0.05)。结论:在子宫肌瘤手术的患者中应用临床路径缩短了患者的住院时间,降低了住院费用,提高了患者对医护人员的满意度,取得了良好的经济效益和社会效益。
Objective: To investigate the value of Clinical Pathway in the operation of patients myoma of uterus. Methods: A total of 60 patients with myoma of uterus were randomly divided into two groups: test group (n=30) was carried outf clinical pathways and a standardized management; control group, a routine way. Then the average length of stay, average hospital charges and satisfaction of the two groups were compared. Results: This article analyses the average dates of hospitalization, treatment fees and composition of the fees, T values of dates of hospitalization, treatment fees and level of satisfaction is 4.42,3.52 and 3.05 respectively (P 〈0.05). Conclusions: Applying the clinical pathway to the operation of patients with myoma of uterus can shorten the average length of stay, reduce hospital costs and increase the satisfaction ,which is benefit to hospitals.
出处
《现代生物医学进展》
CAS
2011年第15期2901-2903,共3页
Progress in Modern Biomedicine
关键词
临床路径
子宫平滑肌瘤
应用评价
Clinical Pathway
Myoma of uterus
Evaluate the application